201 related articles for article (PubMed ID: 16253722)
1. Kidney volume and plasma hepatocyte growth factor-transforming growth factor beta1 ratio among children with biliary atresia before and after liver transplantation: the reversibility of nephromegaly.
Cheng CH; Tsau YK; Tsai IJ
Am J Kidney Dis; 2005 Nov; 46(5):830-6. PubMed ID: 16253722
[TBL] [Abstract][Full Text] [Related]
2. Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia.
Tsau YK; Jou ST; Ni YH
Pediatr Nephrol; 2002 Jul; 17(7):554-9. PubMed ID: 12172775
[TBL] [Abstract][Full Text] [Related]
3. Nephromegaly and elevated plasma hepatocyte growth factor-transforming growth factor-beta1 ratio in infants with fulminant hepatitis or biliary atresia.
Tsau YK; Lu MY; Ni YH
Am J Kidney Dis; 2001 Aug; 38(2):279-85. PubMed ID: 11479153
[TBL] [Abstract][Full Text] [Related]
4. Nephromegaly and elevated hepatocyte growth factor in children with biliary atresia.
Tsau YK; Chen CH; Chang MH; Teng RJ; Lu MY; Lee PI
Am J Kidney Dis; 1997 Feb; 29(2):188-92. PubMed ID: 9016888
[TBL] [Abstract][Full Text] [Related]
5. Transient reciprocal change of renal hepatocyte growth factor and transforming growth factor-beta1 may relate to renal hypertrophy in rats with liver injury or unilateral nephrectomy.
Tsau YK; Tsai IJ; Chen YM
Pediatr Res; 2006 Apr; 59(4 Pt 1):494-9. PubMed ID: 16549518
[TBL] [Abstract][Full Text] [Related]
6. Nephromegaly in children with Kawasaki disease: new supporting evidence for diagnosis and its possible mechanism.
Huang HP; Lai YC; Tsai IJ; Chen SY; Cheng CH; Tsau YK
Pediatr Res; 2008 Feb; 63(2):207-10. PubMed ID: 18091351
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation.
Ninomiya M; Harada N; Shiotani S; Hiroshige S; Minagawa R; Soejima Y; Suehiro T; Nishizaki T; Shimada M; Sugimachi K
Transpl Int; 2003 Nov; 16(11):814-9. PubMed ID: 12879228
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hepatocyte growth factor in patients with biliary atresia.
Hsieh CS; Huang LT; Lee SY; Huang CC; Lee CL; Chuang JH; Chen CL
J Pediatr Surg; 2008 Jul; 43(7):1333-7. PubMed ID: 18639691
[TBL] [Abstract][Full Text] [Related]
9. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.
Vejchapipat P; Theamboonlers A; Poomsawat S; Chittmittrapap S; Poovorawan Y
Eur J Pediatr Surg; 2008 Dec; 18(6):415-8. PubMed ID: 19012231
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 in plasma and liver of children with liver disease.
Rosensweig JN; Omori M; Page K; Potter CJ; Perlman EJ; Thorgeirsson SS; Schwarz KB
Pediatr Res; 1998 Sep; 44(3):402-9. PubMed ID: 9727721
[TBL] [Abstract][Full Text] [Related]
11. The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia.
Uchida K; Inoue M; Otake K; Yoshiyama S; Toiyama Y; Hiro J; Araki T; Miki C; Kusunoki M
J Pediatr Surg; 2006 Oct; 41(10):1657-62. PubMed ID: 17011264
[TBL] [Abstract][Full Text] [Related]
12. Identification of transforming growth factors actively transcribed during the progress of liver fibrosis in biliary atresia.
Lee SY; Chuang JH; Huang CC; Chou MH; Wu CL; Chen CM; Hsieh CS; Chen CL
J Pediatr Surg; 2004 May; 39(5):702-8. PubMed ID: 15137003
[TBL] [Abstract][Full Text] [Related]
13. Children undergoing liver transplantation for treatment of inherited metabolic diseases are prone to higher oxidative stress, complement activity and transforming growth factor-β1.
Hussein MH; Hashimoto T; Suzuki T; Daoud GA; Goto T; Nakajima Y; Kato T; Hibi M; Tomishige H; Hara F; Kato S; Kakita H; Kamei M; Ito T; Kato I; Sugioka A; Togari H
Ann Transplant; 2013 Feb; 18():63-8. PubMed ID: 23792503
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
[TBL] [Abstract][Full Text] [Related]
15. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.
Ramm GA; Nair VG; Bridle KR; Shepherd RW; Crawford DH
Am J Pathol; 1998 Aug; 153(2):527-35. PubMed ID: 9708812
[TBL] [Abstract][Full Text] [Related]
16. Expression of transforming growth factor-β1 and connective tissue growth factor in congenital biliary atresia and neonatal hepatitis liver tissue.
Li FB; Zhao H; Peng KR; Gao ZG; Huang SJ; Tou JF; Shu XL; Gu WZ
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909983
[TBL] [Abstract][Full Text] [Related]
17. Serum hepatocyte growth factor and clinical outcome in biliary atresia.
Vejchapipat P; Theamboonlers A; Chaokhonchai R; Chongsrisawat V; Chittmittrapap S; Poovorawan Y
J Pediatr Surg; 2004 Jul; 39(7):1045-9. PubMed ID: 15213896
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta and hepatocyte growth factor plasma levels in patients with inflammatory bowel disease.
Sturm A; Schulte C; Schatton R; Becker A; Cario E; Goebell H; Dignass AU
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):445-50. PubMed ID: 10783999
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor levels in livers and serum at Kasai-portoenterostomy are not predictive of clinical outcome in infants with biliary atresia.
Madadi-Sanjani O; Kuebler JF; Dippel S; Gigina A; Falk CS; Vieten G; Petersen C; Klemann C
Growth Factors; 2019 Apr; 37(1-2):68-75. PubMed ID: 31185750
[TBL] [Abstract][Full Text] [Related]
20. Serum and tissue transforming [corrected] growth factor β1 in children with biliary atresia.
de Oliveira Fdos S; Kieling CO; dos Santos JL; de Leon Lima PP; Vieira S; Meurer L; da Silveira TR; Matte U
J Pediatr Surg; 2010 Sep; 45(9):1784-90. PubMed ID: 20850621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
